Efficacy of Laparoscopic Sleeve Gastrectomy in Mildly Obese Patients with Body Mass Index of 30-35 kg/m(2).

Park, Ji Yeon; Kim, Yong Jin
Obesity surgery
2015Aug ; 25 ( 8 ) :1351-7.
PMID : 25656261
ÀúÀÚ »ó¼¼Á¤º¸
Park, Ji Yeon -
Kim, Yong Jin -
ABSTRACT
BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) has recently gained rapidly increasing popularity as a stand-alone procedure for the treatment of morbid obesity. This study aimed to evaluate the efficacy of LSG in mildly obese patients with a body mass index (BMI) of 30-35 kg/m(2).

METHODS: One hundred ninety-two patients who consecutively underwent LSG between April 2009 and December 2012 were retrospectively reviewed. The patients were classified into a lower BMI (30-35 kg/m(2)) and higher BMI group (>35 kg/m(2)). Demographics and surgical outcomes were compared between the groups.

RESULTS: Forty-nine patients (25.5 %) belonged to the lower BMI group, while the other 143 (74.5 %) to the higher BMI group. The preoperative BMI of each group was 32.7?±?1.6 and 42.6?±?6.6 kg/m(2), respectively. Severe complications requiring invasive intervention developed only in the higher BMI group (4/143, 2.8 %). The percent of excess weight loss (%EWL) in the lower BMI group was 86.1 % at mean follow-up of 24 months, which was significantly greater than in the higher BMI group (61.9 %, p<0.001). Serial follow-up showed that %EWL was significantly greater in the lower BMI group until 2 years postoperatively, and the difference became statistically insignificant thereafter. The resolution of comorbidities was observed in more than 80 % of the patients both in lower and higher BMI groups. CONCLUSION: LSG achieved excellent outcomes without severe complications for mildly obese patients. LSG could serve as a safe and effective stand-alone procedure to achieve sustained weight loss and comorbidity resolution in patients with a lower BMI.
na
MESH
Adult, *Body Mass Index, Comorbidity, Female, Gastrectomy/*methods, Humans, Laparoscopy/*methods, Male, Middle Aged, Obesity/epidemiology/*surgery, Retrospective Studies, Severity of Illness Index, Treatment Outcome, Weight Loss, Young Adult
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
LSG could be a safe and effective procedure to achieve sustained weight loss and comorbidity resolution in patients with a lower BMI (30-35 kg/m).
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1007/s11695-015-1575-0.
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå